Latest News about SNY
Recent news which mentions SNY
From Benzinga
2 Biopharma Stocks Making Big Moves Tuesday
June 20, 2023
From Motley Fool
Sanofi Stock Is Trading Higher Today - Here's Why
June 20, 2023
From Benzinga
2 Best Biotech Stocks to Buy Right Now
June 16, 2023
From Motley Fool
From Benzinga
From Benzinga
Unanimous Support for AstraZeneca and Sanofi's Nirsevimab: Next Generation RSV Treatment on the Horizon
June 09, 2023
From Benzinga
Why Shares of Innate Pharma Jumped Thursday
June 08, 2023
From Motley Fool
The 7 Most Reliable Dividend Stocks to Buy Now
June 06, 2023
From InvestorPlace
From MarketWatch
3 Biotech Stocks to Avoid Like the Plague
May 23, 2023
From InvestorPlace
From Benzinga
2 Bear Market Defying Stocks to Buy in May
May 22, 2023
From Motley Fool
From MarketWatch
Roche's Investigational Drug For Relapsing Multiple Sclerosis Reduces Brain Lesions, Data Shows
May 17, 2023
From Benzinga
From InvestorPlace
Rebates or Patent Abuse? Eli Lilly, Novo Nordisk, and Sanofi CEOs Cross Swords with PBMs in Senate Hearing
May 12, 2023
From Benzinga
From Benzinga
From MarketWatch
Fabry Disease Treatment Showdown: Protalix Bio's Elfabrio Joins the Ranks of Sanofi and Amicus Therapeutics
May 10, 2023
From Benzinga
7 Blue-Chip Stocks to Buy in May 2023
May 04, 2023
From InvestorPlace
From Benzinga
From InvestorPlace
From Benzinga
European Union's Amended COVID-19 Vaccine Deal with Pfizer-BioNTech: Near-Monopoly Status Potential Threat to Rivals
May 01, 2023
From Benzinga
Sanofi In-Licenses Pompe Disease Therapy From Privately-Held Maze Therapeutics For $150M Upfront
May 01, 2023
Tickers
SNY
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.